<DOC>
	<DOC>NCT02933151</DOC>
	<brief_summary>To conduct a pragmatic randomized clinical trial in which the researchers will determine the mortality impact of a protocol whereby all hemodialysis patients receive an oral, protein-based nutritional supplement during the dialysis procedure as compared to the existing nutritional protocol whereby only hemodialysis patients with serum albumin below 3.5 g/dL and incident hemodialysis patients during the first months of care receive an oral, intradialytic protein-based nutritional supplement during the dialysis procedure.</brief_summary>
	<brief_title>Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial)</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<criteria>1. Receipt of incenter hemodialysis in a facility participating in the trial 2. Able to consume oral nutritional supplements 3. Age â‰¥18 years 1. Tube feed or intravenous feed dependent 2. Unable to feed oneself or request help with feeding if a supplement is provided 3. Known allergy to ingredient(s) of the supplement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>